Odyssey Therapeutics to Showcase Data on OD-07656 at ACG 2024
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving treatments for autoimmune and inflammatory diseases, announced that new translational data for its RIPK2 scaffolding inhibitor, OD-07656, will be presented…
Medibank Urges Expansion of Home Hospital Care
Medibank is advocating for a significant expansion of hospital care in the home to ease pressure on the traditional hospital system. A new KPMG report commissioned by Medibank outlines potential…
Henry Schein Medical Launches at EMS & FIRE PRO Expo
Henry Schein Medical, part of Henry Schein, Inc. (Nasdaq: HSIC), is exhibiting at the EMS & FIRE PRO Expo from October 24-26, 2024. Located at booth #718, the exhibit features…
Elucid Secures Fifth Medicare Contractor for AI Coronary Plaque Coverage
Elucid has announced that Noridian will begin covering AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ™ image analysis software, starting December 8, 2024. With this decision, five out of…
Jupiter Endovascular Treats First U.S. Patient with Vertex Pulmonary Embolectomy System
Jupiter Endovascular, Inc., a medical technology startup focused on pioneering endovascular procedures with its Endoportal Control™ platform, has announced the successful treatment of the first U.S. patient in the SPIRARE…
Vertex Updates on Kidney Programs at ASN Annual Congress
Vertex Pharmaceuticals (Nasdaq: VRTX) has shared updates on its pipeline for kidney diseases, including IgA nephropathy (IgAN), primary membranous nephropathy (pMN), and APOL1-mediated kidney disease (AMKD). The updates highlight the…
Centene Corporation Reports Q3 2024 Results
Centene Corporation (NYSE: CNC) has announced its financial results for the third quarter ending September 30, 2024. Key highlights include: CEO Sarah M. London noted, “Our diversified portfolio has allowed…
Siemens Healthineers to Automate Patient Testing, Addressing Lab Workflow and Staffing Issues
Siemens Healthineers is revolutionizing clinical lab automation by consolidating 25 tasks typically performed manually by staff, significantly reducing manual workflow steps by 75%. Traditional lab automation relies on a track…
HCA Healthcare Reports Q3 2024 Results
HCA Healthcare, Inc. (NYSE: HCA) has released its financial results for the third quarter ending September 30, 2024. Key Metrics: CEO Sam Hazen praised the team for their response to…
CVS Health Foundation Addresses Care Barriers for Chronic Disease Patients in Atlanta
The CVS Health® Foundation has announced a $1.5 million funding initiative to enhance access to healthcare services, medically tailored meals, and transportation for chronic disease patients in Atlanta. This funding…
WellSky® Acquires Bonafide® to Enhance Home Medical Equipment Solutions
WellSky, a prominent technology company in health and community care, has announced its acquisition of Bonafide, a software solution designed for durable medical equipment (DME) and home medical equipment (HME)…
Modalis Gets Orphan Drug Designation for MDL-101 in LAMA2-CMD
Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883, CEO: Haru Morita) has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to MDL-101, a novel…